HL
ABMD

Harding Loevner’s Abiomed Inc ABMD Stock Holding History

Harding Loevner’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-118
Closed -$29K – 161
2022
Q3 		$29K Hold
118
– – ﹤0.01% 113
2022
Q2 		$29K Hold
118
– – ﹤0.01% 114
2022
Q1 		$28K Hold
118
– – ﹤0.01% 113
2021
Q4 		$42K Hold
118
– – ﹤0.01% 115
2021
Q3 		$38K Hold
118
– – ﹤0.01% 109
2021
Q2 		$37K Hold
118
– – ﹤0.01% 117
2021
Q1 		$38K Buy
118
+55
+87% +$17.6K ﹤0.01% 119
2020
Q4 		$20K Hold
63
– – ﹤0.01% 129
2020
Q3 		$17K Hold
63
– – ﹤0.01% 159
2020
Q2 		$15K Buy
+63
New +$12.7K ﹤0.01% 129

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Harding Loevner's ABMD Position: Q4 2022 in Review

Harding Loevner sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 118 shares — an estimated $29K sold.

Harding Loevner first reported a position in ABMD in Q2 2020 and held it in 10 quarters. The position peaked at $42K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Harding Loevner reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Harding Loevner sold 118 Abiomed Inc shares in Q4 2022, an estimated $29K.
  • Harding Loevner first reported a position in Abiomed Inc in Q2 2020 and held it in 10 quarters.
  • Harding Loevner's Abiomed Inc position peaked at $42K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Harding Loevner's 13F filing for Q4 2022, filed 14 Feb 2023.